BattistaOrlanda A., Mental Drugs, Childon Co., Philadelphia, 1960.
3.
BrodieCharles M., “Chlorpromazene as Anxiety-Reducer Effects on Complex Learning and Reaction Time,” Journal of Experimental Research in Personality, Academic Press, N.Y. and London, Vol. 2, Number 2, May, 1967.
4.
BrownJ. A. Mascia, “An Exploratory Study of the Effects of Tranquilizers on Paired Associate Learning,” Psychological Report, 1958, 4:583.
5.
DenhoffEric, LauferMaurice, et al., “The Syndromes of Cerebral Dysfunction.”, Journal of Pediatrics50:4:463, April, 1957.
6.
DoyleP. J. “Organic Hyperkinetic Syndrome,” Journal of School Health, 32:299–306, October, 1962.
7.
FaretaGloria, M.D., GazunConcepcion, M.D., “The Use of Drug Combination in Pediatric Psychiatry,” Current Therapeutic Research, Vol. 6, No. 5, May, 1964.
8.
GladstonIago, Behind the Sulfa Drugs, D. Appleton-Century Co., N.Y., 1943.
9.
HammondJerrold E., M.D., “Drugs for Treatment of Children With Behavior Disorders: Toward A More Specific Use of Them,” Medical Times, Vol. 92, May, 1964.
10.
HawkeryM. C., “Don't Dodge the Drug Question; Stimulants,” Science Teacher, 33: November, 1966.
11.
KrechDavid, “The Chemistry of Learning,” Saturday Review, 51:3, January 20, 1968.
12.
LauferMaurice, M.D., “Cerebral Dysfunction and Behavior Disorders in Adolescents,” The American Journal of Orthopsychiatry, Vol. XXXII, No. 3, April, 1962.
13.
LauferMaurice, EricDenhoff, “Hyperkinetic Behavior Syndrome in Children,” The Journal of Pediatrics, Vol. 50, No. 4, April, 1957.
14.
LauferMaurice, DenhoffEric, et al., “Hyperkinetic Impulse Disorders in Children's Behavior-Problems,” Psychosomatic Medicine, Vol. XIX, No. 1, 1957.
15.
MarleyFaye, “Drug Effects,” Science Newsletter, June 3, 1967, 91:520.
16.
McConnellT. R., “Studies in Activity Level Effects of Amphetamine,” American Journal of Mental Disfunctions68:647–651, March, 1964.
17.
McIlwainHenry, Chemotherapy and the Central Nervous System, Little, Brown, Boston, 1957.
18.
MillerAlbert B., 1966Physician's Desk Reference, 20th Edition to Pharmaceutical Specialties and Biologicals, Medical Economics, Inc., New Jersey, 1965.
19.
MosleyFaye, “Drug Effects,” Science Newsletter, 91:520, June 3, 1967.
20.
PletscherA., “Basic Aspects of Psychotropic Drug Action,” American Journal of Medical Deficiency, 67:238, September, 1962.
21.
RadinS. S., “Psychologican Aspects of Drug Addiction,” Journal of School Health, December, 1966, 36:581–7.
22.
RemmenEdmund, CohenSidney, DitmanKeith S., FrantzJohn Russell, Psychochemotherapy, Western Medical Publications, Los Angeles, California, 1962.
23.
RussellRoger W., “Drugs as Tools In Behavioral Research,” Drugs and Behavior, UhrLeonard, Ed., John Wiley & Sons, Inc., 1960.
24.
SarasonSeymour B., Anxiety In Elementary School Children, Witty, New York, 1960.
25.
Scherings Corporation, The Nature of Brain Function, #8 Investigation, Techniques for Localizing Psychatropic Agents' Action Sites, New Jersey, 1964.
26.
SchragerJ., et al., “Hyperkinetic Children,” Exceptional Child, Vol. 32, May, 1966.
27.
SolomonsGerald, M.D., “The Hyperactive Child,” Journal of the Iowa Medical Society, Vol. 35, August, 1965.
28.
“Memory Pills, Experimenting with Cyclent,” 87:56, June 24, 1956.
29.
TurnerThomas, The Effect of Pharmacologic Agents On The Nervous System, The Williams and Wilkins Co., 1959.
30.
UhrLeonard and MillerJames G., Drugs and Behavior, John Wiley and Sons, Inc., 1960.
31.
“Medicines, the Growing Worry Over Side Effects,” Changing Times, December, 1966.